Research results showed that patients diagnosed with Oral Squamous CellCarcinoma presented higher IL-6 levels than people without cancer while the disease stage progression yielded greater IL-6 increases.This research shows that IL-6 presents itself as a promising non-invasive biomarker for detection and tracking of OSCC through salivaanalysis. Here, IL6 is linked to cancer.